Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)
FMS moved a median of -0.01% 30 minutes after news, and +0.10% by the close. How FMS actually reacts to news — the realized, point-in-time move the market made, measured across 150 labeled events over the last three years with zero look-ahead.
FMS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.04% | 43% | 149 |
| 30-min | -0.01% | 48% | 150 |
| 60-min | +0.05% | 53% | 150 |
| to close | +0.10% | 52% | 150 |
| Middle 50% of FMS reactions | -0.25% to +0.29% |
|---|---|
| Median reaction (30-min) | -0.01% |
| Measured reactions | 150 |
Half of all Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) news events land between -0.25% and +0.29% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How FMS reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 16 | -0.11% | 38% | +0.39% |
| Analyst downgrades | 23 | +0.08% | 57% | -0.14% |
| Coverage initiations | 23 | -0.20% | 22% | +0.20% |
| Rating reiterations | 16 | +0.09% | 56% | -0.09% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how FMS ranks against every other measured name →
That’s how FMS usually reacts — get an email when it moves on news →Email me when FMS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to FMS's baseline. Nothing else.
Recent FMS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K Fresenius Medical Care For: Oct 07 | SEC filing · Form 6-K | SEC EDGAR | -0.22% | -0.58% | |
| Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth | Press release | PR Newswire | +0.46% | -0.43% | |
| Form 6-K Fresenius Medical Care For: Sep 25 | SEC filing · Form 6-K | SEC EDGAR | -0.18% | +1.07% | |
| Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership | Press release | PR Newswire | +0.27% | +0.58% | |
| Form 6-K Fresenius Medical Care For: Aug 27 | SEC filing · Form 6-K | SEC EDGAR | +0.26% | +0.34% | |
| Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis | Press release | PR Newswire | +0.26% | +0.34% | |
| Form 6-K Fresenius Medical Care For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | -0.45% | -0.37% | |
| Form 6-K Fresenius Medical Care For: Aug 03 | SEC filing · Form 6-K | SEC EDGAR | — | -0.30% | |
| Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda | Press release | PR Newswire | -0.02% | -0.49% | |
| Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery | Press release | PR Newswire | -0.02% | -0.49% | |
| Form 6-K Fresenius Medical Care For: Jul 29 | SEC filing · Form 6-K | SEC EDGAR | +0.04% | -0.44% | |
| Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients | Press release | PR Newswire | +0.04% | -0.44% | |
| Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy | Press release | PR Newswire | -0.04% | -0.21% | |
| Thailand Launches "Thailand Health Excellence 2026" The Next Chapter of Global Healing Advancing Thailand as a Global Health & Healing Destination supported by TAT | Press release | PR Web | -0.30% | +0.94% | |
| Form 11-K Fresenius Medical Care For: Dec 31 | SEC filing · Form 11-K | SEC EDGAR | -0.13% | +0.58% | |
| Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis | Press release | PR Newswire | -0.29% | +0.53% | |
| Form 6-K Fresenius Medical Care For: May 28 | SEC filing · Form 6-K | SEC EDGAR | -0.23% | +0.37% | |
| Form SD Fresenius Medical Care | SEC filing · Form SD | SEC EDGAR | -0.23% | +0.37% | |
| Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million | Press release | PR Newswire | -0.23% | +0.37% | |
| Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 | Press release | PR Newswire | +0.00% | -0.60% | |
| Form 6-K Fresenius Medical Care For: May 26 | SEC filing · Form 6-K | SEC EDGAR | +0.35% | -0.28% | |
| Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months | Press release | PR Newswire | -0.68% | -1.73% | |
| Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care | Press release | PR Newswire | -0.11% | +0.20% | |
| Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer | Press release | PR Newswire | -0.11% | +0.04% | |
| Form 6-K Fresenius Medical Care For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | +0.81% | -0.76% | |
| Form 6-K Fresenius Medical Care For: May 05 | SEC filing · Form 6-K | SEC EDGAR | -1.66% | -4.22% | |
| Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed | Press release | PR Newswire | -1.66% | -4.22% | |
| Form 6-K Fresenius Medical Care For: Apr 14 | SEC filing · Form 6-K | SEC EDGAR | -0.21% | -1.69% | |
| Form 20-F Fresenius Medical Care For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -0.09% | -0.37% | |
| Form 6-K Fresenius Medical Care For: Feb 24 | SEC filing · Form 6-K | SEC EDGAR | -0.49% | +0.40% | |
| Form IRANNOTICE Fresenius Medical Care | SEC filing · Form IRANNOTICE | SEC EDGAR | -0.22% | -0.53% | |
| Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band | Press release | PR Newswire | -0.49% | +0.40% | |
| Form 6-K Fresenius Medical Care For: Jan 12 | SEC filing · Form 6-K | SEC EDGAR | -0.52% | -0.38% | |
| Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned | Press release | PR Newswire | +0.28% | -0.56% | |
| Form 6-K Fresenius Medical Care For: Dec 10 | SEC filing · Form 6-K | SEC EDGAR | +0.09% | +0.86% | |
| Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board | Press release | PR Newswire | +0.26% | +1.65% | |
| Form 6-K Fresenius Medical Care For: Nov 17 | SEC filing · Form 6-K | SEC EDGAR | -0.02% | -0.88% | |
| Form 6-K Fresenius Medical Care For: Nov 04 | SEC filing · Form 6-K | SEC EDGAR | -0.29% | +1.89% | |
| Form 6-K Fresenius Medical Care For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | -0.29% | +1.89% | |
| Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 | Press release | PR Newswire | -0.29% | +1.89% | |
| Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 | Press release | PR Newswire | +0.11% | -1.44% | |
| Form 6-K Fresenius Medical Care For: Oct 01 | SEC filing · Form 6-K | SEC EDGAR | +0.11% | +0.68% | |
| Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement | Press release | PR Newswire | +0.15% | +0.87% | |
| Form 6-K Fresenius Medical Care For: Sep 19 | SEC filing · Form 6-K | SEC EDGAR | +0.04% | -0.47% | |
| Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment | Press release | PR Newswire | -0.08% | +0.16% | |
| Form 6-K Fresenius Medical Care For: Aug 11 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.00% | |
| Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework | Press release | PR Newswire | +0.00% | +0.00% | |
| Form 6-K Fresenius Medical Care For: Aug 05 | SEC filing · Form 6-K | SEC EDGAR | -1.57% | -1.49% | |
| Form 6-K Fresenius Medical Care For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | -0.33% | -0.73% | |
| Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 | Press release | PR Newswire | -1.57% | -1.49% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the FMS section they belong to.
Where else FMS is measured.
FMS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) | 150 | +0.84% | 57% |
| Electromed, Inc. (ELMD) | 150 | 0.00% | 43% |
| Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL) | 149 | 0.00% | 42% |
| BioLineRx Ltd. - American Depositary Shares (BLRX) | 148 | -0.82% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)'s median reaction calculated?
Every labeled FMS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 150 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of FMS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does FMS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.